Author Archives: Fredricko
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
Growcentia appoints Darrin Paschal as new chief commercial officer
Read the original:
Growcentia appoints Darrin Paschal as new chief commercial officer
Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium
Here is the original post:
Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium
COMPASS Pathways plc to announce third quarter 2022 financial results on 3 November 2022
Read the original here:
COMPASS Pathways plc to announce third quarter 2022 financial results on 3 November 2022
Myriad Genetics to Release Third-Quarter Financial Results on Nov. 1, 2022
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
Terns Pharmaceuticals to Present Positive Clinical Data in NASH at AASLD The Liver Meeting® 2022
4D Molecular Therapeutics Interim Clinical Data from the On-going Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease to be Presented…
MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call
Travere Therapeutics Announces Presentations and Posters at American Society of Nephrology Kidney Week 2022
ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
Syncona Commences Tender Offer for All Outstanding Shares of Applied Genetic Technologies Corporation
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
Update: Growcentia appoints Darrin Paschal as new chief commercial officer
argenx Reports Third Quarter 2022 Financial Results and Provides Business Update
Originally posted here:
argenx Reports Third Quarter 2022 Financial Results and Provides Business Update